A Serosurvey of Japanese Encephalitis Virus in Monkeys and Humans Living in Proximity in Thailand

Japanese encephalitis virus (JEV) is a member of the Flaviviridae family and one of Asia’s most common causes of encephalitis. JEV is a zoonotic virus that is transmitted to humans through the bite of infected mosquitoes of the Culex species. While humans are dead-end hosts for the virus, domestic animals such as pigs and birds are amplification hosts. Although JEV naturally infected monkeys have been reported in Asia, the role of non-human primates (NHPs) in the JEV transmission cycle has not been intensively investigated. In this study, we demonstrated neutralizing antibodies against JEV in NHPs (Macaca fascicularis) and humans living in proximity in two provinces located in western and eastern Thailand by using Plaque Reduction Neutralization Test (PRNT). We found a 14.7% and 5.6% seropositive rate in monkeys and 43.7% and 45.2% seropositive rate in humans living in west and east Thailand, respectively. This study observed a higher seropositivity rate in the older age group in humans. The presence of JEV neutralizing antibodies in NHPs that live in proximity to humans shows the occurrence of natural JEV infection, suggesting the endemic transmission of this virus in NHPs. According to the One Health concept, regular serological studies should be conducted especially at the animal–human interface.

[1]  S. Yoksan,et al.  Seroepidemiological study of Japanese encephalitis virus in Chiang Mai: Immunity and susceptibility 28 years after introduction of a vaccination programme , 2022, PLoS neglected tropical diseases.

[2]  A. Fuentes,et al.  First survey on seroprevalence of Japanese encephalitis in long-tailed macaques (Macaca fascicularis) in Bali, Indonesia , 2022, Veterinary world.

[3]  M. R. Hassan,et al.  Seroepidemiological Studies on Japanese Encephalitis: A Systematic Review , 2021, Oman medical journal.

[4]  M. Muramatsu,et al.  Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012 , 2021, mSphere.

[5]  A. Siqueira,et al.  Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil , 2020, BMC Infectious Diseases.

[6]  P. Tulayakul,et al.  Seroprevalence of Dengue, Zika, and Chikungunya Viruses in Wild Monkeys in Thailand. , 2020, The American journal of tropical medicine and hygiene.

[7]  Dong Hyun Kim,et al.  Seroprevalence of Neutralizing Antibodies against Japanese Encephalitis Virus among Adolescents and Adults in Korea: A Prospective Multicenter Study , 2020, Vaccines.

[8]  C. Murdock,et al.  Sylvatic cycles of arboviruses in non-human primates , 2019, Parasites & Vectors.

[9]  G. T. Selvarajah,et al.  Prevalence and risk factors of Japanese encephalitis virus (JEV) in livestock and companion animal in high-risk areas in Malaysia , 2017, Tropical Animal Health and Production.

[10]  M. Han,et al.  Correction: Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010 , 2016, PloS one.

[11]  A. Lindberg,et al.  One Health surveillance - More than a buzz word? , 2015, Preventive veterinary medicine.

[12]  M. A. Islam,et al.  Dynamics of Japanese Encephalitis Virus Transmission among Pigs in Northwest Bangladesh and the Potential Impact of Pig Vaccination , 2014, PLoS neglected tropical diseases.

[13]  Pesus Chou,et al.  The Incidence of Japanese Encephalitis in Taiwan—A Population-Based Study , 2014, PLoS neglected tropical diseases.

[14]  H. Shimoda,et al.  Seroprevalence of Japanese encephalitis virus infection in captive Japanese macaques (Macaca fuscata) , 2014, Primates.

[15]  J. Gonzalez,et al.  Dengue, Japanese encephalitis and Chikungunya virus antibody prevalence among captive monkey (Macaca nemestrina) colonies of Northern Thailand , 2014, American journal of primatology.

[16]  A. Maeda,et al.  Review of diagnostic plaque reduction neutralization tests for flavivirus infection. , 2013, Veterinary journal.

[17]  P. Daszak,et al.  One Health: The Human-Animal-Environment Interfaces in Emerging Infectious Diseases: Food Safety and Security, and International and National Plans for Implementation of One Health Activities , 2013 .

[18]  S. Hills,et al.  Estimated global incidence of Japanese encephalitis: a systematic review. , 2011, Bulletin of the World Health Organization.

[19]  C. Klade,et al.  Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers. , 2011, Vaccine.

[20]  Nikos Vasilakis,et al.  Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health , 2011, Nature Reviews Microbiology.

[21]  S. Dowell,et al.  Japanese encephalitis virus remains an important cause of encephalitis in Thailand. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[22]  A. Barrett,et al.  Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. , 2008, Viral immunology.

[23]  I. Kurane,et al.  Cross-reactive IgM responses in patients with dengue or Japanese encephalitis. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  I. Kurane,et al.  Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. , 2005, Vaccine.

[25]  O. Tomori.  Yellow Fever: The Recurring Plague , 2004, Critical reviews in clinical laboratory sciences.

[26]  S. Inoue,et al.  Distribution of three arbovirus antibodies among monkeys (Macaca fascicularis) in the Philippines , 2003, Journal of medical primatology.

[27]  A. Barrett,et al.  Japanese Encephalitis and West Nile Viruses , 2012, Current Topics in Microbiology and Immunology.

[28]  T. Tsai.  New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. , 2000, Vaccine.